Biosimilars
These companies develop and sell cheaper copies of biologic drugs once the original patents expire.
+11.7%
over 3 months · S&P 500 −2.1%
Key indicators
Health
52 / 100
Fragile
Solid
Price
P/E 50
Cheap
Expensive
Up over 1 year
5 of 7
Wallets over 90 days
1 / 3 buys / sells
Buys
Sells
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 7 companies
AMGN
+11.7%
Size: weight in the tag. Color: move over the period.